Natural antibodies and the autoimmunity of atherosclerosis

[1]  Tatsuhiko Kodama,et al.  Lysophosphatidylcholine Enhances Cytokine Production of Endothelial Cells via Induction of L-Type Amino Acid Transporter 1 and Cell Surface Antigen 4F2 , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[2]  D. Broide,et al.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. , 2004, The Journal of clinical investigation.

[3]  G. Getz,et al.  Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice Published, JLR Papers in Press, April 21, 2004. DOI 10.1194/jlr.M400075-JLR200 , 2004, Journal of Lipid Research.

[4]  B. Strauss,et al.  Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein , 2004, Circulation.

[5]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[6]  K. Takatsu,et al.  The Role of IL-5 for Mature B-1 Cells in Homeostatic Proliferation, Cell Survival, and Ig Production 1 , 2004, The Journal of Immunology.

[7]  K. Walsh,et al.  Impaired Clearance of Apoptotic Cells Promotes Synergy between Atherogenesis and Autoimmune Disease , 2004, The Journal of experimental medicine.

[8]  R. Hardy,et al.  Selection during development of VH11+ B cells: a model for natural autoantibody‐producing CD5+ B cells , 2004, Immunological reviews.

[9]  P. Askenase,et al.  Cutaneous Immunization Rapidly Activates Liver Invariant Vα14 NKT Cells Stimulating B-1 B Cells to Initiate T Cell Recruitment for Elicitation of Contact Sensitivity , 2003, The Journal of experimental medicine.

[10]  M. Päivänsalo,et al.  Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis , 2003, Circulation.

[11]  M. Briehl,et al.  Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells. , 2003, Biochimica et biophysica acta.

[12]  E. Wright,et al.  Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation , 2003, Oncogene.

[13]  A. Lacy-Hulbert,et al.  Apoptotic Cells and Innate Immune Stimuli Combine to Regulate Macrophage Cytokine Secretion 1 , 2003, The Journal of Immunology.

[14]  B. Fadeel,et al.  Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[15]  J. Witztum,et al.  The Autoreactivity of Anti-Phosphorylcholine Antibodies for Atherosclerosis-Associated Neo-Antigens and Apoptotic Cells 12 , 2003, The Journal of Immunology.

[16]  S. Baksh,et al.  Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal , 2003, Cell.

[17]  J. Witztum,et al.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.

[18]  A. Zuercher,et al.  B1 Cells Contribute to Serum IgM, But Not to Intestinal IgA, Production in Gnotobiotic Ig Allotype Chimeric Mice1 , 2003, The Journal of Immunology.

[19]  Joseph Juliano,et al.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[20]  S. Shinton,et al.  Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development , 2003, The Journal of experimental medicine.

[21]  Y. Shoenfeld,et al.  Anti-idiotypes to Oxidized LDL Antibodies in Intravenous Immunoglobulin Preparations--Possible Immunomodulation of Atherosclerosis , 2003, Autoimmunity.

[22]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[23]  Daniel Steinberg,et al.  Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime , 2002, Nature Medicine.

[24]  J. Witztum,et al.  Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.

[25]  M. Linton,et al.  B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Yijun Deng,et al.  Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36* , 2002, The Journal of Biological Chemistry.

[27]  M. Lopes-Virella,et al.  Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. , 2002, Clinical immunology.

[28]  J. Witztum,et al.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  N. Brot,et al.  I-PLA2 Activation during Apoptosis Promotes the Exposure of Membrane Lysophosphatidylcholine Leading to Binding by Natural Immunoglobulin M Antibodies and Complement Activation , 2002, The Journal of experimental medicine.

[30]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[31]  M. Radic,et al.  Blebs and Apoptotic Bodies Are B Cell Autoantigens1 , 2002, The Journal of Immunology.

[32]  C. Come,et al.  Influence of C3 Deficiency on Atherosclerosis , 2002, Circulation.

[33]  M. Fishbein,et al.  Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes , 2002, Circulation research.

[34]  U. Ikeda,et al.  Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. , 2002, Atherosclerosis.

[35]  H. Wardemann,et al.  B-1a B Cells that Link the Innate and Adaptive Immune Responses Are Lacking in the Absence of the Spleen , 2002, The Journal of experimental medicine.

[36]  G. Hansson,et al.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. , 2002, The Journal of clinical investigation.

[37]  E. Dennis,et al.  Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids , 2002, The Journal of Biological Chemistry.

[38]  B. Binder,et al.  Oxidized Membrane Vesicles and Blebs From Apoptotic Cells Contain Biologically Active Oxidized Phospholipids That Induce Monocyte‐Endothelial Interactions , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Marc Bonneville,et al.  Autoreactivity by design: innate B and T lymphocytes , 2001, Nature Reviews Immunology.

[40]  P. Libby,et al.  CD40 Signaling and Plaque Instability , 2001, Circulation research.

[41]  A. Tedgui,et al.  Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction , 2001, Circulation.

[42]  M. Radic,et al.  Structural basis for autoantibody recognition of phosphatidylserine-β2 glycoprotein I and apoptotic cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Tew,et al.  Phosphorylcholine-Dependent Cross-Reactivity between Dental Plaque Bacteria and Oxidized Low-Density Lipoproteins , 2001, Infection and Immunity.

[44]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[45]  S. Kaveri,et al.  Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. , 2001, The New England journal of medicine.

[46]  Pojen P. Chen,et al.  Human-Derived Anti-Oxidized LDL Autoantibody Blocks Uptake of Oxidized LDL by Macrophages and Localizes to Atherosclerotic Lesions In Vivo , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[47]  C. Schindler,et al.  Lymphocytes are important in early atherosclerosis. , 2001, The Journal of clinical investigation.

[48]  A. Rosen,et al.  Clearing the way to mechanisms of autoimmunity , 2001, Nature Medicine.

[49]  C. Snapper,et al.  Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. , 2001, Trends in immunology.

[50]  J. Bluestone,et al.  Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[51]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[52]  Virgil L. Woods,et al.  Anticardiolipin Antibodies From Patients With the Antiphospholipid Antibody Syndrome Recognize Epitopes in Both &bgr;2-Glycoprotein 1 and Oxidized Low-Density Lipoprotein , 2001, Circulation.

[53]  OlovWiklund,et al.  Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A2 , 2001 .

[54]  G. Bondjers,et al.  Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A2 , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[55]  Anders Hamsten,et al.  LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[56]  B. Fagerberg,et al.  Antibodies to Oxidized LDL in Relation to Intima-Media Thickness in Carotid and Femoral Arteries in 58-Year-Old Subjectively Clinically Healthy Men , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[57]  R. Hardy,et al.  B cell development pathways. , 2001, Annual review of immunology.

[58]  F. Tron,et al.  Overlap of the anti‐cardiolipin and anti‐nucleosome responses of the (NZW X BXSB)F1 mouse strain: a new pattern of cross‐reactivity for lupus‐related autoantibodies , 2000, European journal of immunology.

[59]  M. Yen,et al.  Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. , 2000, Atherosclerosis.

[60]  D. Steinberg,et al.  The oxidative modification hypothesis of atherogenesis: an overview. , 2000, Free radical biology & medicine.

[61]  J. Berliner,et al.  Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. , 2000, Free radical biology & medicine.

[62]  G. Silverman,et al.  Immunological responses to oxidized LDL. , 2000, Free radical biology & medicine.

[63]  G. Silverman,et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.

[64]  J. Kearney.  Immune recognition of OxLDL in atherosclerosis. , 2000, The Journal of clinical investigation.

[65]  J. Kearney,et al.  B‐cell subsets and the mature ­preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory” , 2000, Immunological reviews.

[66]  D. Longo,et al.  Positive and negative selection of antigen-specific B cells in transgenic mice expressing variant forms of the V(H)1 (T15) heavy chain. , 2000, International immunology.

[67]  A. Lustig,et al.  Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Wagner,et al.  Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. , 2000, Circulation.

[69]  G. Krings,et al.  Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. , 2000, Clinical immunology.

[70]  T. Honjo,et al.  Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III , 2000, The Journal of experimental medicine.

[71]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[72]  M. Neuberger,et al.  Deficiency in Serum Immunoglobulin (Ig)m Predisposes to Development of Igg Autoantibodies , 2000, The Journal of experimental medicine.

[73]  A. Tarakhovsky,et al.  B-1 cells: orthodox or conformist? , 2000, Current opinion in immunology.

[74]  J. Witztum,et al.  Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis , 2000, Journal of internal medicine.

[75]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[76]  G. Hansson,et al.  Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[77]  F. Kroese,et al.  B-1 cells and the intestinal microflora. , 2000, Current topics in microbiology and immunology.

[78]  M. Uusitupa,et al.  Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[79]  M. Bureau,et al.  Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.

[80]  Jian Ye,et al.  Selection at Multiple Checkpoints Focuses VH12 B Cell Differentiation toward a Single B-1 Cell Specificity , 1999, The Journal of experimental medicine.

[81]  J. Silver,et al.  Positive selection of natural autoreactive B cells. , 1999, Science.

[82]  E. Dennis,et al.  Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[83]  E. Dennis,et al.  Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Renauld,et al.  Interleukin 9–induced In Vivo Expansion of the B-1 Lymphocyte Population , 1999, The Journal of experimental medicine.

[85]  B. Rollins,et al.  MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. , 1999, The Journal of clinical investigation.

[86]  L. Herzenberg,et al.  Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[87]  K. Seidl,et al.  Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Harnett,et al.  Phosphorylcholine: friend or foe of the immune system? , 1999, Immunology today.

[89]  J. Freyssinet,et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.

[90]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[91]  D. Mevorach,et al.  Complement-dependent Clearance of Apoptotic Cells by Human Macrophages , 1998, The Journal of experimental medicine.

[92]  E. Miller,et al.  Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[93]  S. Kaveri,et al.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. , 1998, The Journal of clinical investigation.

[94]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[95]  M. Neuberger,et al.  Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[96]  T. Kodama,et al.  Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system , 1998, Cellular and Molecular Life Sciences CMLS.

[97]  A Afek,et al.  Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. , 1998, Atherosclerosis.

[98]  S. Clarke,et al.  B-1 Cell Development: Evidence for an Uncommitted Immunoglobulin (Ig)M+ B Cell Precursor in B-1 Cell Differentiation , 1998, The Journal of experimental medicine.

[99]  K. Takatsu,et al.  Interleukin 5 and B cell differentiation. , 1998, Cytokine & growth factor reviews.

[100]  P. Shah,et al.  Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. , 1997, Journal of the American College of Cardiology.

[101]  J. Witztum,et al.  The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[102]  A Daugherty,et al.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.

[103]  A. Coutinho,et al.  The repertoire of serum IgM in normal mice is largely independent of external antigenic contact , 1997, European journal of immunology.

[104]  L A Herzenberg,et al.  Frequent occurrence of identical heavy and light chain Ig rearrangements. , 1997, International immunology.

[105]  J. D. Smith,et al.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[106]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[107]  L. Herzenberg,et al.  An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. , 1997, Journal of immunology.

[108]  A. Daugherty,et al.  Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[109]  P. Shah,et al.  Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[110]  J. Witztum,et al.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.

[111]  J. Miyazaki,et al.  Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. , 1996, Immunity.

[112]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[113]  P. Casali,et al.  Structure and function of natural antibodies. , 1996, Current topics in microbiology and immunology.

[114]  T. Honjo,et al.  Administration of interleukin ‐5 or ‐10 activates peritoneal B‐1 cells and induces autoimmune hemolytic anemia in anti‐erythrocyte autoantibody‐transgenic mice , 1995, European journal of immunology.

[115]  S. Young,et al.  Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[116]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[117]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[118]  A. Coutinho,et al.  Natural autoantibodies. , 1995, Current opinion in immunology.

[119]  V. Ord,et al.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[120]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.

[121]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[122]  D. Spencer,et al.  Mechanisms that limit the diversity of antibody: three sequentially acting mechanisms that favor the spontaneous production of germline encoded anti-phosphatidyl choline. , 1993, International immunology.

[123]  D. Steinberg,et al.  Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. , 1993, The Journal of clinical investigation.

[124]  L. Herzenberg,et al.  B-cell lineages exist in the mouse. , 1993, Immunology today.

[125]  J L Witztum,et al.  Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[126]  J. Kearney,et al.  The Fetal Omentum in Mice and Humans , 1992, Annals of the New York Academy of Sciences.

[127]  M. Howard,et al.  Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells , 1992, The Journal of experimental medicine.

[128]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[129]  M. Howard,et al.  Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10 , 1992, European journal of immunology.

[130]  G. Hansson,et al.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[131]  A. Feeney.  Comparison of junctional diversity in the neonatal and adult immunoglobulin repertoires. , 1992, International reviews of immunology.

[132]  A. Coutinho,et al.  All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. , 1990, International immunology.

[133]  J L Witztum,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[134]  G. Morahan,et al.  The peritoneal Ly‐1 (CD5) B cell repertoire is unique among murine B cell repertoires , 1990, European journal of immunology.

[135]  L. Herzenberg,et al.  Toward a layered immune system , 1989, Cell.

[136]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[137]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[138]  J. Steinberg.  Book ReviewAmbulatory Pediatric Care , 1989 .

[139]  D. Steinberg,et al.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[140]  H. Lutz,et al.  Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[141]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[142]  L. McDaniel,et al.  Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia. , 1984, Journal of immunology.

[143]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[144]  M. Rittenberg,et al.  Subpopulations of antibodies to phosphocholine in human serum. , 1984, Journal of immunology.

[145]  D. Briles,et al.  Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae , 1982, The Journal of experimental medicine.

[146]  P. Edwards,et al.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[147]  N. Sigal,et al.  The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice. , 1975, Journal of immunology.